Head-to-head · Cost-Efficiency Index
Metaboost Rx vs Vea Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Metaboost Rx
Shoppers who don't mind entering an eligibility funnel to get a firm, itemized quote.
Visit Metaboost RxVea Health
Shoppers comfortable completing a full intake before seeing any price, in exchange for a broader microdosing menu.
Visit Vea HealthThe verdict
Metaboost Rx and Vea Health tie on the Cost-Efficiency Index at 54/100, so neither wins outright on the numbers. For most shoppers we'd start with Metaboost Rx (ranked #359, a hair above #366) — Shoppers who don't mind entering an eligibility funnel to get a firm, itemized quote. But Vea Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Metaboost Rx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Metaboost Rx | Vea Health |
|---|---|---|
| Cost-Efficiency Index | 54/100 | 54/100 |
| Semaglutide / mo | $249/mo (starting dose, compounded) | Not disclosed |
| Tirzepatide / mo | $299/mo (starting dose, compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $2,988 | — |
| Tirzepatide / yr (modeled) | $3,588 | — |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Yes |
| Rank here | #359 | #366 |
Metaboost Rx
54/100Where the value is
- Publishes at least headline starting prices on the homepage, unlike some peers that hide all numbers
- '$0 if not approved' guarantee reduces risk of a wasted consultation fee
- Offers a microdose GLP-1 tier alongside standard semaglutide/tirzepatide
The tradeoffs
- Homepage price and product-page pricing don't match up -- dose tiers and confirmed rates are never shown together
- No named medical director or compounding pharmacy partner disclosed
Vea Health
54/100Where the value is
- Verified LegitScript certification with a working checker link (seal ID 48955268)
- Offers a genuine microdosing tier for both semaglutide and tirzepatide alongside the standard dose
- Repeats the FDA compounded-medication disclaimer on every page, and states 'Provider approval required. Not all patients qualify' rather than implying automatic approval
The tradeoffs
- Zero pricing is published anywhere on the public site — the entire catalog is gated behind the intake quiz
- No compounding pharmacy is named anywhere; the site only says 'domestic, pharmacy-grade suppliers' and 'FDA-registered, cGMP-certified facilities'
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.